Repare Therapeutics

7210 Frederick-Banting
Suite 100
St-Laurent
Quebec
H4S 2A1
Canada

Email: info@reparerx.com

Show jobs for this employer

About Repare Therapeutics

Repare is developing new, precision oncology drugs for patients that target specific vulnerabilities of tumor cells. Its approach integrates insights from several fields of cell biology including DNA repair and synthetic lethality. Repare’s platform combines a proprietary, high-throughput, CRISPR-enabled gene editing target discovery method with high-resolution protein crystallography, computational biology and clinical informatics. The company is backed by leading global healthcare investors including founding investor Versant Ventures and MPM Capital.
YEAR FOUNDED:
2016
LEADERSHIP:
Founders: Daniel Durocher, PhD., Frank Sicheri, PhD and Agnel Sfeir, PhD
President & CEO: Lloyd M. Segal
EVP, Business & Corporate Development: Kim Seth
VP, Discovery: Cameron Black
EVP, Head of R&D: Michael Zinda
CAREER:
Please click here for Repare Therapeutics' job opportunities.

11 articles with Repare Therapeutics